Ophthalmology Doctors in Glendora, CA Accepting Medicare

6 Ophthalmology doctors found. Showing 1 - 6

Dr. Kenneth K York, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 210 S Grand Ave, Suite 215, Glendora, CA 91741 Phone: 626-335-0266    Fax: 626-914-6508

Mr. Abraham V Shammas, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1341 South Grand Avenue, 2nd Floor, Glendora, CA 91740 Phone: 626-335-1259    Fax: 626-963-2855

Dr. Mark B Kislinger, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 210 S Grand Ave, Ste 106, Glendora, CA 91741 Phone: 626-335-0535

Jose Cabrera Briones Jr., MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 130 W Route 66, #202, Glendora, CA 91740 Phone: 626-914-4705    Fax: 626-852-0331

Dr. Vicky Chia-pei Pai, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 210 S Grand Ave Ste 106, Glendora, CA 91741 Phone: 626-335-0535    Fax: 626-914-7664

Antoine Garabet, Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 840 N Pennsylvania Ln, Glendora, CA 91741 Phone: 626-391-1298

News Archive

Stat5 protein could serve as biomarker to help guide prostate cancer treatment

Men who had high levels of the activated Stat5 protein in their prostate cancer after a radical prostatectomy were more likely to have a recurrence or die from the disease compared to men who had little to no presence of the growth protein, according to a recent study published in Human Pathology by Jefferson's Kimmel Cancer Center researchers.

Women with high-risk pregnancies far more prone to heart disease

Women who have high-risk pregnancies or complications in childbirth are up to eight times more likely to suffer heart disease later in life. And many mothers — and their doctors — are unaware of the danger.

Lenvatinib therapy improves survival in patients with advanced radioiodine-refractory thyroid cancer

In a pivotal Phase III study led by researchers at The University of Texas MD Anderson Cancer Center, the oral anti-angiogenic therapy lenvatinib has shown dramatic improvement in progression-free survival in patients with advanced radioiodine-refractory thyroid cancer.

Study: More attention needs to be paid for cartilage during RA diagnosis

This could lead to a paradigm shift in the treatment of rheumatoid arthritis: rheumatologists at the Medical University of Vienna have discovered, through a secondary study involving 3,000 female patients, that the condition of the cartilage in inflammatory joint rheumatism needs to be paid more attention than has previously been the case. Until now, the focus lay mainly on investigating the damage to the bone.

Read more Medical News

› Verified 1 days ago